Development of the vaccine against borreliosis for human use
| Project: | Development of the vaccine against borreliosis for human use |
|---|---|
| Research institute: | Bioveta, a. s. |
| Description: | |
| "Bioveta, a.s. has isolated gene sequence for OspC antigens of Borrelia afzelii, Borrelia burgdorferi sensu stricto and Borrelia garinii. At the same time Bioveta, a.s. has prepared recombinant proteins corresponding to the above mentioned sequences and own technological procedure for the production of recombinant proteins, intended for preparation of the vaccine against borreliosis for human use. These results are a part of the complex and exigent project of the human vaccine development." | |
